154 related articles for article (PubMed ID: 22434858)
1. Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.
Toll L; Pajak K; Plazinska A; Jozwiak K; Jimenez L; Kozocas JA; Tanga MJ; Bupp JE; Wainer IW
Mol Pharmacol; 2012 Jun; 81(6):846-54. PubMed ID: 22434858
[TBL] [Abstract][Full Text] [Related]
2. Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β₂-adrenergic receptor.
Plazinska A; Pajak K; Rutkowska E; Jimenez L; Kozocas J; Koolpe G; Tanga M; Toll L; Wainer IW; Jozwiak K
Bioorg Med Chem; 2014 Jan; 22(1):234-46. PubMed ID: 24326276
[TBL] [Abstract][Full Text] [Related]
3. The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the beta(2)-adrenoceptor.
Jozwiak K; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Biochem Pharmacol; 2010 Jun; 79(11):1610-5. PubMed ID: 20144591
[TBL] [Abstract][Full Text] [Related]
4. Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.
Jozwiak K; Plazinska A; Toll L; Jimenez L; Woo AY; Xiao RP; Wainer IW
Chirality; 2011; 23 Suppl 1(Suppl 1):E1-6. PubMed ID: 21618615
[TBL] [Abstract][Full Text] [Related]
5. Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.
Plazinska A; Kolinski M; Wainer IW; Jozwiak K
J Mol Model; 2013 Nov; 19(11):4919-30. PubMed ID: 24043542
[TBL] [Abstract][Full Text] [Related]
6. Stereochemistry of an agonist determines coupling preference of beta2-adrenoceptor to different G proteins in cardiomyocytes.
Woo AY; Wang TB; Zeng X; Zhu W; Abernethy DR; Wainer IW; Xiao RP
Mol Pharmacol; 2009 Jan; 75(1):158-65. PubMed ID: 18838481
[TBL] [Abstract][Full Text] [Related]
7. Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.
Jozwiak K; Khalid C; Tanga MJ; Berzetei-Gurske I; Jimenez L; Kozocas JA; Woo A; Zhu W; Xiao RP; Abernethy DR; Wainer IW
J Med Chem; 2007 Jun; 50(12):2903-15. PubMed ID: 17506540
[TBL] [Abstract][Full Text] [Related]
8. Agonist binding by the β2-adrenergic receptor: an effect of receptor conformation on ligand association-dissociation characteristics.
Plazinska A; Plazinski W; Jozwiak K
Eur Biophys J; 2015 Apr; 44(3):149-63. PubMed ID: 25726162
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective binding of agonists to the β
Plazinska A; Plazinski W
Mol Biosyst; 2017 May; 13(5):910-920. PubMed ID: 28338133
[TBL] [Abstract][Full Text] [Related]
10. Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.
Reinartz MT; Kälble S; Wainer IW; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2015 May; 388(5):517-24. PubMed ID: 25637582
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of airway smooth muscle histamine H(1) receptor mRNA, protein, and function by beta(2)-adrenoceptor activation.
Mak JC; Roffel AF; Katsunuma T; Elzinga CR; Zaagsma J; Barnes PJ
Mol Pharmacol; 2000 May; 57(5):857-64. PubMed ID: 10779367
[TBL] [Abstract][Full Text] [Related]
12. Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.
Beigi F; Bertucci C; Zhu W; Chakir K; Wainer IW; Xiao RP; Abernethy DR
Chirality; 2006 Nov; 18(10):822-7. PubMed ID: 16917835
[TBL] [Abstract][Full Text] [Related]
13. {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.
Toll L; Jimenez L; Waleh N; Jozwiak K; Woo AY; Xiao RP; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2011 Feb; 336(2):524-32. PubMed ID: 21071556
[TBL] [Abstract][Full Text] [Related]
14. Modeling of ligand binding to G protein coupled receptors: cannabinoid CB1, CB2 and adrenergic β 2 AR.
Latek D; Kolinski M; Ghoshdastider U; Debinski A; Bombolewski R; Plazinska A; Jozwiak K; Filipek S
J Mol Model; 2011 Sep; 17(9):2353-66. PubMed ID: 21365223
[TBL] [Abstract][Full Text] [Related]
15. Analysis of full and partial agonists binding to beta2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes.
Katritch V; Reynolds KA; Cherezov V; Hanson MA; Roth CB; Yeager M; Abagyan R
J Mol Recognit; 2009; 22(4):307-18. PubMed ID: 19353579
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptor activation correlates with the proapoptotic action of the β2-adrenergic agonist (R,R')-4-methoxy-1-naphthylfenoterol in HepG2 hepatocarcinoma cells.
Paul RK; Ramamoorthy A; Scheers J; Wersto RP; Toll L; Jimenez L; Bernier M; Wainer IW
J Pharmacol Exp Ther; 2012 Oct; 343(1):157-66. PubMed ID: 22776956
[TBL] [Abstract][Full Text] [Related]
17. Differential signaling of the endogenous agonists at the beta2-adrenergic receptor.
Reiner S; Ambrosio M; Hoffmann C; Lohse MJ
J Biol Chem; 2010 Nov; 285(46):36188-98. PubMed ID: 20837485
[TBL] [Abstract][Full Text] [Related]
18. Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.
de Boer RE; Steegstra MR; Kroezen PA; Smit J; Zaagsma J
Br J Pharmacol; 1996 Dec; 119(7):1355-60. PubMed ID: 8968543
[TBL] [Abstract][Full Text] [Related]
19. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
20. Stereoselectivity at the beta2-adrenoceptor on macrophages is a major determinant of the anti-inflammatory effects of beta2-agonists.
Izeboud CA; Vermeulen RM; Zwart A; Voss HP; van Miert AS; Witkamp RF
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):184-9. PubMed ID: 10961382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
